CAJ | 학술논문

目的对口服抗血小板药物的分类和应用现状以及市场份额进行分析，进而了解中国口服抗血小板药物市场的特点和发展趋势。方法通过二手数据库分析方法和描述性统计分析，对样本数据采用量化分析，对中国的口服抗血小板药物市场进行深入的研究。结果在国内市场中，阿司匹林是唯一拥有众多国内外众多指南推荐使用的抗血药，仍作为临床一线用药。结论未来新型口服抗血小板药物的开发，在于寻找出有效性高、安全性大，性价比高，且患者依从性高的口服抗血小板药物。
목적대구복항혈소판약물적분류화응용현상이급시장빈액진행분석，진이료해중국구복항혈소판약물시장적특점화발전추세。방법통과이수수거고분석방법화묘술성통계분석，대양본수거채용양화분석，대중국적구복항혈소판약물시장진행심입적연구。결과재국내시장중，아사필림시유일옹유음다국내외음다지남추천사용적항혈약，잉작위림상일선용약。결론미래신형구복항혈소판약물적개발，재우심조출유효성고、안전성대，성개비고，차환자의종성고적구복항혈소판약물。
objective: classification of oral antiplatelet agents and the application situation and market share analysis, to understand the characteristics of Chinese oral antiplatelet drugs market and development trend. Method: through the second-hand database analysis and descriptive statistical analysis, adopts the quantitative analysis of sample data, the market for Chinese oral antiplatelet drugs for in-depth research. Results: in the domestic market, aspirin was the only one with a lot of domestic and international numerous guidelines recommended blood drug resistance, for clinical medication and aspirin. Conclusion: the new oral antiplatelet drugs development, the future is to find out the effectiveness, safety, high cost performance is high, and high adherence in patients with oral antiplatelet drugs.